BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5232498)

  • 1. Impairment of diabetic control by norethynodrel with mestranol.
    Reder JA; Tulgan H
    N Y State J Med; 1967 Apr; 67(8):1073-4. PubMed ID: 5232498
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptives and intravenous glucose tolerance. II. Long-term effect.
    Posner NA; Silverstone FA; Pomerance W; Singer N
    Obstet Gynecol; 1967 Jan; 29(1):87-92. PubMed ID: 6017950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation and oral ovulostatic steroids. (Case studies of 22 women treated for a long period, from 6 months to 3 years, with norethynodrel and mestranol)].
    Conti M; Neglia V; Arrotta U
    Minerva Ginecol; 1967 Nov; 19(22):1091-4. PubMed ID: 5606233
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral contraceptives and intravenous glucose tolerance. I. Data noted early in treatment.
    Posner NA; Silverstone FA; Pomerance W; Baumgold D
    Obstet Gynecol; 1967 Jan; 29(1):79-86. PubMed ID: 6017949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Galactorrhea induced by oral contraceptives].
    Sas M; Kincses L; Resch B
    Orv Hetil; 1973 Nov; 114(47):2845-6. PubMed ID: 4796441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic therapy of cerebral thrombosis caused by Infecundin].
    Gaszner P; Herr G; Mezei B
    Orv Hetil; 1974 Apr; 115(16):924-6. PubMed ID: 4821198
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary infarct during treatment with an oral contraceptive (norethylnodrel + mestranol)].
    Hazard J; Modaï J; Moulin S; Vuagnat P; Domart A
    Sem Hop; 1967 Mar; 43(15):991-3. PubMed ID: 4292991
    [No Abstract]   [Full Text] [Related]  

  • 8. Norethynodrel with mestranol and venous blood flow.
    Neistadt A; Schwartz RW; Schwartz SI
    JAMA; 1966 Nov; 198(7):784-5. PubMed ID: 5953344
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombo-embolic accidents in the course of treatment by a progestagen-estrogen combination].
    Grasset J
    Sem Ther; 1966 Jan; 42(1):22-35. PubMed ID: 5986621
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormones and their influence in epilepsy.
    Sánchez Longo LP; González Saldaña LE
    Acta Neurol Latinoam; 1966; 12(1):29-47. PubMed ID: 6014827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional state of the hypothalamo-hypophyseal system in women taking oral gestagens].
    Sokolova ZP; Tkachenko NM
    Sov Med; 1971 Jul; 34(7):134-5. PubMed ID: 5160318
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term experience with Enovid among clinic patients: results after 2 and one-half to 6 years of individual patient use.
    Sturtevant RP
    J Reprod Med; 1970 Aug; 5(2):90-5. PubMed ID: 5521775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver dysfunction with mestranol but not with norethynodrel in a patient with Enovid-induced jaundice.
    Urban E; Frank BW; Kern F
    Ann Intern Med; 1968 Mar; 68(3):598-602. PubMed ID: 5643682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apropos of the appearance of chloasma during treatment with synthetic progestational agents].
    Rivoire J
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(3):353-4. PubMed ID: 5962578
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased factor 8 levels in suspected carriers of hemophilia A taking contraceptives by mouth.
    Schiffman S; Rapaport SI
    N Engl J Med; 1966 Sep; 275(11):599. PubMed ID: 5920414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal factors in dermatitis herpetiformis].
    Haim S; Friedman-Birnbaum R
    Harefuah; 1971 Nov; 81(10):500-1. PubMed ID: 5141853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Microglandular hyperplasia of endocervical glands as a consequence of the use of oral contraceptives].
    Damjanov I
    Lijec Vjesn; 1970; 92(9):1049-54. PubMed ID: 5207408
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chloasmic type of pigmentation of the face during treatments with estrogens and progestational hormones].
    Basset H
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(2):166-8. PubMed ID: 6061306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic function and oral ovulostatic drugs].
    Conti M; Neglia V
    Ann Ostet Ginecol Med Perinat; 1968 Aug; 90(8):554-60. PubMed ID: 5740536
    [No Abstract]   [Full Text] [Related]  

  • 20. Enovid therapy (norethynodrel with mestranol) for fibrocystic disease.
    Ariel IM
    Am J Obstet Gynecol; 1973 Oct; 117(4):453-9. PubMed ID: 4743352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.